Delivery Order SPE2DB22D3501-SPE2DB24FUG11
Award Date
1/22/24
Potential Completion Date
1/23/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,722.07 contract is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, to support military treatment programs and facilities. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and has...
This is a $1,071.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,909,446 units of the pharmaceutical product Atovaquone-Proguanil 250-100. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. No set-aside was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,768.68, is for the provision of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,787.40 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has a period of performance through March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,026,392 units of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The $65,274.00 contract has a performance period through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is a standalone delivery order and not associated with any larger contract...
This is a $60,332.77 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product Atovaquone-proguanil 250-100 100s, with a performance period through April 2024. The contract has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,083.70 firm fixed-price delivery order is for the supply of 4,566,197,978 units of Atovaquone-Proguanil 250-100mg tablets. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Atovaquone-Proguanil 250-100 100s medication. The contract has a firm fixed price of $2,184.67 and a performance period ending on April 26, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly to the Department of Defense (DoD) and...
This is a $4,953.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for ATOVAQUONE-PROGUANIL 250-100 UD 24S, a medical product, with a period of performance through February 26, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $10,464.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...